About Michelle Xia
Michelle Xia was a Chinese biochemist and business executive.
Early life and education Xia was born in Gansu province. In 1996, she moved to the United States to conduct cancer research at the University of Louisville. Since 2023, she has served on the board of Summit Therapeutics.
Under Xia, Akeso have developed Ivonescimab, which appears to outperform Pembrolizumab (marketed as Keytruda), produced by Merck in the US.
In March 2025, she was included in the "TIME100 Health" list.
As of July 2025, Forbes estimates her net worth at US$1.2 billion.
Don’t just read it —
keep it.
Full-length biographies made to live with: read them, listen on the way to work, watch them tonight.
- E-book
- Audio
- Video
Instant download · yours to keep · every purchase keeps this site free
Important facts
Related people
Same field, nearest in time
Frequently asked questions
Who was Michelle Xia?
Chinese biochemist and entrepreneur
What was Michelle Xia's occupation?
Michelle Xia was a biochemist and business executive.
What nationality was Michelle Xia?
Michelle Xia was Chinese.
Sources & further reading
Cite this page
APA: Biography.guide. (2026). Michelle Xia. https://biography.guide/michelle-xia/
MLA: "Michelle Xia." Biography.guide, https://biography.guide/michelle-xia/.
Chicago: "Michelle Xia." Biography.guide. https://biography.guide/michelle-xia/.
Data last updated: 2026-09-20 · Spot an error? Report a correction.
Page generated 2026-09-27 05:17 UTC